Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a spot of snow forecast to arrive on the Pharmalot campus. Our short people are as busy as ever, our official mascot is happily snoozing, and our coffee kettle is fired up. So what more could we ask? Well, we could always use a few secret dossiers. So while you consider how to forward them, please enjoy the menu of tidbits assembled below. This is a busy world, indeed. Hope your day goes well …

Japan offers easy access to new medicines, whose prices are decided by the government and subsidized by a public health insurance system, but that may change, Reuters explains. Confronted with the ballooning cost of caring for an aging population, the government is introducing a cost-effectiveness test for drugs as a means of capping prices. Drug makers say the system, which will be adopted in April, may chase new medicines out of the market, while patients also fear more drastic changes, such as denying access to new treatments.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!